ASTM E2080-14

4.1 Clinical PDD examinations refer to the employment of polygraph instrumentation for the purpose of detecting deception or verifying truthfulness of statements of individuals under court supervision, or in treatment for the commission of a sex offense.

4.2 Clinical PDD examinations are specifically intended to assist in the detection, treatment, or supervision of sex offenders.

4.3 Clinical PDD testing should be regarded as a decision-support tool intended to assist professionals in making important decisions regarding risk and safety assessments. Clinical PDD testing should not replace the need for other forms of behavioral monitoring or traditional forms of supervision and field investigations.

1.1 This guide establishes procedures for conducting a clinical polygraph examination (CPE), to include, but not limited to, post conviction sex offender testing (PCSOT). This PDD model is specifically intended to assist in the treatment and supervision of sex offenders on probation, parole, or a deferred prosecution alternative.

1.2 This guide also applies to the conduct of clinical polygraph examinations for therapeutic purposes when requested by a presiding legal authority.

1.3 This guide directs that such examiners for this application are specifically trained in issues associated with supervision and treatment of sex offenders.